NEW YORK (GenomeWeb News) – CombiMatrix today said that it has received notice from Nasdaq that it has regained full compliance with the exchange's minimum bid continued listing requirement.
Registering provides access to this and other free content.
Already have an account?Login Now.
The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.
In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.
Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.
In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.